Talk:Perampanel: Difference between revisions

>Fycompah21
Adding content
 
>Fycompah21
m Fixing content
Line 7: Line 7:


<!-- Please ensure that any new substance articles are first published in the 'Talk' namespace. For example, a new article on substance XYZ should have the title "Talk: XYZ" instead of "XYZ". Once the submitted article has been reviewed and determined to meet the guidelines and standards, it will be published by a staff member. -->
<!-- Please ensure that any new substance articles are first published in the 'Talk' namespace. For example, a new article on substance XYZ should have the title "Talk: XYZ" instead of "XYZ". Once the submitted article has been reviewed and determined to meet the guidelines and standards, it will be published by a staff member. -->
For tips on how to properly format a substance article, please refer to this document: [[Content Style Guide - Substance]]


Perampanel (also known as Fycompa) is a synthetic non-competitive antagonist of the AMPA receptor, belonging to the class of dissociatives and categorized as an anticonvulsant
Perampanel (also known as Fycompa) is a synthetic non-competitive antagonist of the AMPA receptor, belonging to the class of dissociatives and categorized as an anticonvulsant
Return to "Perampanel" page.